Elanco EVP Buys $96K in Company Stock (ELAN)
Elanco Animal Health Inc
Subscribe to track ELAN
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Elanco EVP Buys $96K in Company Stock (ELAN)
Company: Elanco Animal Health Inc (ELAN) Form: 4 | Filed: 2025/12/15 Significance: Low
Insider: Modi Rajeev A. Title: Executive Vice President U.S. Pet Health and Global Digital Transformation | Relationship: Officer
Transaction: • Type: Purchase • Shares: 4,500 • Price: $21.33 • Value: $95,985 • Owned After: 123,082
Key Insight: An executive purchased shares, which is a positive sign, but the transaction value is very small compared to the company's $10.48B market cap, making it a low-significance event.
Market Context: This is a routine-sized open market purchase for an executive at a large-cap company. It increases the insider's holdings by approximately 3.8%.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Elanco Animal Health Inc (ELAN)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An executive made a small open-market purchase of common stock, representing a minor increase in their personal holdings and an immaterial transaction relative to the company's market capitalization.
- Market Impact: The transaction is too small to have a meaningful impact on the stock's price or trading volume.
Company Information
| Field | Value |
|---|---|
| Company | Elanco Animal Health Inc |
| Ticker Symbol | ELAN |
| CIK | 0001739104 |
| Industry | Pharmaceutical Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | Modi Rajeev A. |
| CIK | 0001916473 |
| Title/Position | Executive Vice President U.S. Pet Health and Global Digital Transformation |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-12-11 |
| Transaction Code | P (Open market purchase) |
| Security Type | Common Stock |
| Shares Involved | 4,500 |
| Price Per Share | $21.33 |
| Total Value | $95,985 |
| Shares Owned After | 123,082 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $95,985 |
| % of Market Cap | 0.0009% |
| Shares Transacted | 4,500 |
| % of Shares Outstanding | Not Available |
| Post-Transaction Ownership | 123,082 shares |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: Elanco Animal Health Inc. is a large-cap company with a market capitalization of $10.48 billion. The transaction value of approximately $96k is negligible in this context.
- Ownership Concentration: The insider's post-transaction holding is 123,082 shares. Without data on total shares outstanding, a precise ownership percentage cannot be calculated, but it is expected to be a very small fraction of the company.
- Transaction Significance: The purchase represents less than 0.001% of the company's market capitalization. This falls far below the thresholds for moderate or high significance, indicating a routine transaction with minimal market signaling value.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: While an insider purchase is technically a bullish signal, the transaction size is immaterial relative to the company's market cap. It is unlikely to influence investor sentiment or stock price.
Volume & Sentiment
- Expected Volume Impact: Negligible. The transaction is too small to affect trading volume.
- Sentiment Indicator: Neutral. The purchase is a minor vote of confidence but not substantial enough to be considered a strong bullish indicator.
Additional Context
Transaction Notes
- Footnotes: The filing notes that the total shares owned includes shares acquired via the company's Employee Stock Purchase Plan, which are routine acquisitions.
- Special Circumstances: This was a standard open market purchase (Code 'P') and not part of a pre-arranged 10b5-1 trading plan.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
